Open questions about metabolically normal obesity (Q37820071)

23 August 2017

1 reference

title

Open questions about metabolically normal obesity (English)

1 reference

23 August 2017

0 references

Z Pataky

1

1 reference

23 August 2017

E Bobbioni-Harsch

series ordinal

2

1 reference

23 August 2017

A Golay

series ordinal

3

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 December 2010

1 reference

International Journal of Obesity

23 August 2017

1 reference

23 August 2017

34 Suppl 2

1 reference

23 August 2017

S18-23

1 reference

https://scigraph.springernature.com/pub.10.1038/ijo.2010.235

23 August 2017

0 references

cites work

Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

The disease burden associated with overweight and obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

The metabolically healthy but obese individual presents a favorable inflammation profile

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Prevalence of uncomplicated obesity in an Italian obese population

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Can we identify metabolically healthy but obese individuals (MHO)?

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Identification and characterization of metabolically benign obesity in humans

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Metabolically Healthy but Obese Women Have an Intermediate Cardiovascular Risk Profile Between Healthy Nonobese Women and Obese Insulin-Resistant Women

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Are metabolically normal but obese individuals at lower risk for all-cause mortality?

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Identifying metabolically healthy but obese individuals in sedentary postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Genome-wide association to body mass index and waist circumference: the Framingham Heart Study 100K project

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Gln27Glu variant of Beta2-adrenoceptor gene affects male type fat accumulation in women

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Association of SIRT1 gene variation with visceral obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Role of nonexercise activity thermogenesis in resistance to fat gain in humans.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Genetic analysis of self-reported physical activity and adiposity: the Southwest Ohio Family Study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Genetic selection of mice for high voluntary wheel running: effect on skeletal muscle glucose uptake

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Nutritional epigenomics of metabolic syndrome: new perspective against the epidemic

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Determinants of insulin-resistant phenotypes in normal-weight and obese Black African women

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

The association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

High adiponectin concentrations are associated with the metabolically healthy obese phenotype

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Ectopic lipids and organ function

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Psychosocial profile of the metabolically healthy but obese postmenopausal woman.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Stress, visceral obesity, and metabolic complications

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Duration of overweight and metabolic health risk in American men and women.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Influence of duration of obesity on the insulin resistance of obese non-diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Uncomplicated obesity is associated with abnormal aortic function assessed by cardiovascular magnetic resonance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Five-year alterations in BMI are associated with clustering of changes in cardiovascular risk factors in a gender-dependant way: the Stanislas study

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Metabolically healthy but obese women: effect of an energy-restricted diet

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Weight change, weight cycling and mortality in the ERFORT Male Cohort Study.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Weight cycling and high-density lipoprotein cholesterol in women: evidence of an adverse effect: a report from the NHLBI-sponsored WISE study. Women's Ischemia Syndrome Evaluation Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.235

7 January 2021

Identifiers

DOI

10.1038/IJO.2010.235

1 reference

Dimensions Publication ID

23 August 2017

0 references

1 reference